The nature of the epidermal growth produced by the first application of 12-0-tetradecanoyl-phorbol-13-acetate on the skin of mice initiated with dimethylbenzanthracene.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000494:pharmacology*; D000818:Animals; D001551:Benz(a)Anthracenes / Q000494:pharmacology*; D004817:Epidermis / Q000032:analysis / Q000187:drug effects* / Q000473:pathology; D005260:Female; D006965:Hyperplasia / Q000473:pathology; D051379:Mice; D008938:Mitosis / Q000187:drug effects*; D009929:Organ Size; D010704:Phorbols / Q000494:pharmacology*; D011506:Proteins / Q000032:analysis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D001551:Benz(a)Anthracenes; D010704:Phorbols; D011506:Proteins; D015127:9,10-Dimethyl-1,2-benzanthracene; D013755:Tetradecanoylphorbol Acetate